Duearity AB (publ) (DEAR.ST)
Duearity AB (publ) operates in the Medical - Devices industry of the Healthcare sector, headquartered in Malmö, SE. The stock last traded at $0.02, up 0.00% on the session, giving a market capitalisation of $3.1M. Its beta of 1.80 implies it has historically moved more than the broad market.
Established in Malmö, Sweden, in 2020, Duearity AB (publ) operates in the medical technology sector, specializing in treatments for tinnitus. Their flagship product, Tinearity, is an innovative aid that utilizes a compact sound emitter to produce therapeutic white noise, delivered directly into the user's ear through bone conduction via the skull. Additionally, the company is actively developing Tinearity AI, an artificial intelligence-powered solution intended to empower those affected by tinnitus to effectively control their symptoms.
Duearity AB (publ) is most often compared with the following Healthcare names: